| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/11/2005 | US20050176634 substitution or the elimination ofcysteine residue (Cys) in the C-terminal portion of the wild type protein polypeptide sequence; prevents multimerisation of monomeric form but does not affect dimerisation; storage stability; treatment of ischemia, scleroderma, skin ulcer, aging, burn, wound; cosmetic |
| 08/11/2005 | US20050176632 Angiogenesis inhibitors |
| 08/11/2005 | US20050176146 Using vector transformation to generate heat resistant viral particles |
| 08/11/2005 | US20050176130 Functional mutations in respiratory syncytial virus |
| 08/11/2005 | US20050176122 Isolation of proteins |
| 08/11/2005 | US20050176104 Using overexpression of nucleotide sequences coding tumor associated antigen as diagnostic/prognostic tool in detection of cancer |
| 08/11/2005 | US20050176103 Produced by recombinant techniques and polynucleotides encoding the polypeptides; used to stimulate angiogenesis for wound healing and for vascular tissue repair |
| 08/11/2005 | US20050176094 Polypeptide having immunomodulatory activity, antiviral activity, and antitumor activity; polynucleotides, expression vectors , probes and antibodies; predicting responsiveness to treatment with interferon- alpha and other interferons which act at the Type 1 interferon receptor |
| 08/11/2005 | US20050176077 Using urease as tool in identifying modulators of bacterial propagation; enzyme inhibitors |
| 08/11/2005 | US20050176020 I-CAM related protein |
| 08/11/2005 | US20050176013 Identifying modulators of 3'-phosphoadenosine 5'-phosphosulfate synthase 1(PAPPS-1) activity; antitumor agents; tumor diagnostics |
| 08/11/2005 | US20050175985 Cold-adapted equine influenza viruses |
| 08/11/2005 | US20050175724 Composition for modulating at least one physiological reaction or inducing an immune response in human or animal after oral administration; for intestinal delivery of a physiologically active agent, a neutralizing agent, an inhibitor of digestive enzymes, an uptake increasing agent; synergistic |
| 08/11/2005 | US20050175638 Desensitization immunotherapy; increasing concentration exposure regimen |
| 08/11/2005 | US20050175635 Method and composition |
| 08/11/2005 | US20050175634 Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction |
| 08/11/2005 | US20050175633 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV |
| 08/11/2005 | US20050175632 Vaccine for preventing cervical cancer |
| 08/11/2005 | US20050175631 Hiv vaccine and method of use |
| 08/11/2005 | US20050175630 Lethally irradiated bacteria formulated for mucosal delivery; sensitized allergic disorders |
| 08/11/2005 | US20050175629 Helicobacter pylori vaccination |
| 08/11/2005 | US20050175627 HIV pharmaccines |
| 08/11/2005 | US20050175626 Determining susceptibility; screening for clearance of deposition materials; developing antibodies |
| 08/11/2005 | US20050175625 Cell lines, isolated antibodies, expression vectors, bacterium, fusion proteins, mouse models; inducing cytolytic T cell response in tumors |
| 08/11/2005 | US20050175624 Utilizing vascular epithelial growth factor (VEGFR1) polypeptides, fragments and/or encoding oligonucleotides |
| 08/11/2005 | US20050175621 Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form |
| 08/11/2005 | US20050175619 Methods of producing antibody conjugates |
| 08/11/2005 | US20050175617 Tie-2 ligands, methods of making and uses thereof |
| 08/11/2005 | US20050175616 PCDGF receptor antibodies and methods of use thereof |
| 08/11/2005 | US20050175615 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
| 08/11/2005 | US20050175613 Compositions and methods for treating hyperimmune response in the eye |
| 08/11/2005 | US20050175611 Storage stability, heat resistance; such as cetuximab combined with glycine and polyoxyethylene sorbitan monooleate in aqueous pH 5.5 citrate buffer |
| 08/11/2005 | US20050175609 Placental growth factor as a target for the treatment of osteoporosis |
| 08/11/2005 | US20050175606 Cyclic single-chain trispecific antibody |
| 08/11/2005 | US20050175604 Administering a plurality of two autoimmune inhibitors selected from the group consisting of an antibody to alpha interferon, an antibody to gamma interferon, and an antibody to tumor necrosis factor alpha |
| 08/11/2005 | US20050175603 Reduced-viscosity concentrated protein formulations |
| 08/11/2005 | US20050175602 Mixing protein with a saccharide compound in a liquid suspension and then drying to produce a solid that contains the protein and the saccharide |
| 08/11/2005 | US20050175596 Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells |
| 08/11/2005 | US20050175588 Contain one or more recombinant molecule(s) expressed on a cellular surface and incorporated and/or associated with a particle that does not require cellular entry for delivery; for stimulation of biological processes, inactivation of inhibitory factors, scavenging and/or detoxifying |
| 08/11/2005 | US20050175583 Making vector compositions that mimic the functionality of components of the immune system especially antigen-presenting cell (APC) element of the immune synapse; vaccination |
| 08/11/2005 | US20050175582 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 08/11/2005 | CA2758323A1 Use of amino-oxy functional groups in the preparation of vaccines |
| 08/11/2005 | CA2556849A1 Inhibition of bright function as a treatment for excessive immunoglobulin production |
| 08/11/2005 | CA2554729A1 Polymer-bound antibody cancer therapeutic agent |
| 08/11/2005 | CA2554461A1 Method for obtaining precursor z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency |
| 08/11/2005 | CA2553805A1 Improved inactivated feline calicivirus vaccines |
| 08/11/2005 | CA2552392A1 Apicomplex vaccine strains of a family of sarcocystidae |
| 08/11/2005 | CA2548992A1 Immunotherapy compositions, method of making and method of use thereof |
| 08/10/2005 | EP1561817A2 Modified CEA and uses thereof |
| 08/10/2005 | EP1561470A1 HCV vaccines comprising the envelope-1 (E1) protein or the corresponding DNA and at least one antiviral agent |
| 08/10/2005 | EP1561117A1 Diagnostic and therapeutic use of arl7 for alzheimer's disease |
| 08/10/2005 | EP1560848A2 Ptprk immunogenic peptide |
| 08/10/2005 | EP1560597A2 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| 08/10/2005 | EP1560595A2 Fully human antibody fab fragments with human interferon-gamma neutralizing activity |
| 08/10/2005 | EP1560594A1 Immunization of non-human mammals against streptococcus equi |
| 08/10/2005 | EP1560582A2 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE |
| 08/10/2005 | EP1343826B1 Polysaccharide compound having immune stimulating activity |
| 08/10/2005 | EP1084145B1 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 08/10/2005 | EP1051189B1 Vaccine formulation comprising sugar-alcohols and low concentrations of anorganic ions |
| 08/10/2005 | EP0939652B1 Use of antibodies to cd45ro leukocyte antigen for immunomodulation |
| 08/10/2005 | EP0914150B1 Recombinant neospora antigens and their uses |
| 08/10/2005 | EP0894143B1 Vmp-like sequences of pathogenic borrelia |
| 08/10/2005 | EP0794797B1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 08/10/2005 | EP0597852B2 Swine pneumonia vaccine and method for the preparation thereof |
| 08/10/2005 | CN1653184A Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 08/10/2005 | CN1653183A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 08/10/2005 | CN1653182A Recombinant fowlpox virus |
| 08/10/2005 | CN1653181A Expression of genes in modified vaccinia virus ankara by using the cowpox ATI promoter |
| 08/10/2005 | CN1653177A Muteins of placental growth factor type 1, preparation method and application thereof |
| 08/10/2005 | CN1653176A Compositions and methods for generating an immune response |
| 08/10/2005 | CN1653172A Cotton rat lung cells for virus culture |
| 08/10/2005 | CN1653086A Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis C virus |
| 08/10/2005 | CN1653085A Fusion protein of HIV regulatory/accessory proteins |
| 08/10/2005 | CN1653084A Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 08/10/2005 | CN1653080A Lymphatic and blood endothelial cell genes |
| 08/10/2005 | CN1652821A Human monoclonal antibodies to prostate specific membrane antigen (PSMA) |
| 08/10/2005 | CN1652820A Methods of treatment using CTLA-4 antibodies |
| 08/10/2005 | CN1652819A Attenuation of metapneumovirus |
| 08/10/2005 | CN1652818A Fuel additive |
| 08/10/2005 | CN1652817A Mycoplasma hyopneumoniae bacterin vaccine |
| 08/10/2005 | CN1652816A Methods for the in vitro culture of sporozoea sp. and uses thereof |
| 08/10/2005 | CN1652815A Human monoclonal antibodies to influenza M2 protein and methods of making and using same |
| 08/10/2005 | CN1652814A Induction of antigen specific immunologic tolerance |
| 08/10/2005 | CN1652770A Use of statins and other immunomodulatory agents in the treatment of autoimmune disease |
| 08/10/2005 | CN1651919A CD154 blockade monoclone antibody use for inhibiting rejection of insulin producing tissue transplantation |
| 08/10/2005 | CN1651573A New Aike 30 Virus and its use |
| 08/10/2005 | CN1651458A Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 08/10/2005 | CN1651457A Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens |
| 08/10/2005 | CN1651407A Sodium alkyl acyl acetaldehyde sulfite, its synthesis method and use |
| 08/10/2005 | CN1651083A Preparation method of anti prglet bacterial epidemic disease compound egg antibody medicinal preparation |
| 08/10/2005 | CN1651082A Preparation method of compound egg yolk antibody medicinal preparation for preventing and treating piglet virus epidemic disease |
| 08/10/2005 | CN1651081A 单纯疱疹病毒ⅱ型dna疫苗 Herpes simplex virus type dna vaccine ⅱ |
| 08/10/2005 | CN1651080A Method of preparing rabies live carrier vaccine using gland virus carrier expression rabies virus bigene |
| 08/10/2005 | CN1651071A CD154 blockade therapy for therapeutic protein inhibitor syndrome |
| 08/10/2005 | CN1214044C ErdB3 antibodies |
| 08/10/2005 | CN1214043C Humanized antibodies to gamma-interferon |
| 08/10/2005 | CN1214042C Production process for intravenous immune serum globulin and resultant product |
| 08/10/2005 | CN1214006C Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments |
| 08/10/2005 | CN1213736C Single-shot vaccine formulation |
| 08/09/2005 | US6928368 Gene mining system and method |